Strategy Backtests
Every strategy we test — winners and losers — published with full equity curves, drawdowns and honest verdicts. Real Dukascopy tick data, commission included, out-of-sample validated.
Small-Edges Cross-Family Portfolio
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
Asian Session Range Breakout
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
WMR Fix Reversal
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
USDJPY Triple-Swap Wednesday
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
BTC Donchian Trend
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
Gotobi Tokyo Fix
Dukascopy Tick Data · OOS 2022–2026 · IS 2019–2022 · commission included
Rejected before the out-of-sample stage
These ideas died in research or in-sample testing, before ever touching held-out data. No equity curves to show, on purpose. Each write-up explains what killed it.